suppression remains an unexplained but critical question, the answer to which could optimize the efficacy and acceptability Administration of supraphysiological doses of testosterone of hormonal male contraception. One possible mechanism may to normal men causes inhibition of spermatogenesis, but be differences in residual testicular steroidogenesis despite while most become azoospermic, 30-55% maintain a low suppression of gonadotrophins to undetectable levels rate of spermatogenesis. We have investigated whether (Anderson and Wu, 1996). The degree to which testicular there are differences in endogenous androgen production, steroidogenesis is reduced in the azoospermic and oligozooof testicular and adrenal origin, which may be related to spermic subjects is currently unknown. Unfortunately, measurethe degree of suppression of spermatogenesis. Thirty-three ment of peripheral blood testosterone concentrations does not healthy Caucasian men were given weekly i.m. injections reflect endogenous testicular steroidogenesis during administraof 200 mg testosterone oenanthate (TE), 18 became azoostion of exogenous testosterone. permic, while 15 remained oligozoospermic. Urinary excreEpitestosterone (17α-hydroxyandrost-4-en-3-one) is a nattion of epitestosterone, a specific testicular product, was ural epimer of testosterone secreted predominantly by the testis reduced to <10% of pretreatment values, with no differ- (Dehennin, 1993) and excreted in urine in similar amounts to ences between the groups. Similar results were obtained testosterone (Cowan et al., 1991). Excretion of epitestosterone for other markers of testicular steroidogenesis. Urinary increases following chorionic gonadotrophin administration and plasma adrenal androgens were also reduced during (Cowan et al., 1991) and during puberty (Raynaud et al., 1993) . TE treatment: a statistically significant decrease in both Excretion is drastically suppressed by exogenous testosterone (P < 0.001 and P < 0.05 respectively) was seen in the administration (Dehennin and Matsumoto, 1993) and an azoospermic but not oligozoospermic responders. These increased urinary testosterone/epitestosterone ratio is used for results suggest that testicular steroidogenesis is decreased the detection of surreptitious testosterone administration by to <10% by the administration of supraphysiological doses the International Olympic Committee (Wheeler, 1993) . Since of exogenous testosterone. Differences in the degree of little, if any, epitestosterone is derived from peripheral metabolongoing steroidogenesis in the testis do not appear to ism of testosterone, androstenedione, or dehydroepiandrosaccount for incomplete suppression of spermatogenesis, terone (DHA) (Wilson and Lipsett, 1966) , this steroid can thus differences in androgen metabolism may underlie this therefore serve as a valid index of endogenous testicular heterogeneous response. A small but significant reduction steroidogenesis during administration of exogenous testoin secretion of adrenal androgens was also detectable, the sterone. relevance of which is unclear.
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In this study, we have investigated the possibility that Key words: adrenal androgens/epitestosterone/male contracepdifferences in suppression of endogenous steroidogenesis in tion/spermatogenesis response to supraphysiological doses of exogenous testosterone may be responsible for the heterogeneity in the degree of suppression of spermatogenesis observed in healthy Caucasian Introduction subjects. Urinary epitestosterone, 17-hydroxyprogesterone (17OH-progesterone) and urinary pregnanetriol were used as Abolition of pituitary gonadotrophin secretion by exogenous sex steroids results in testicular atrophy characterized by markers of testicular steroidogenesis. Adrenal androgens may be converted to more potent androcessation of Leydig cell steroidogenesis, intratesticular testosterone depletion and arrest of spermatogenesis. This approach gens such as dehydrotestosterone (DHT) within the prostate in vivo and in vitro (Farnsworth, 1973; Harper et al., 1974) , is currently under evaluation as a method of hormonal male contraception (World Health Organization, 1990 , 1996 . A and also in skin (Kaufman et al., 1990) . Such mechanisms may contribute to the overall androgen precursor pool in the consistent but perplexing finding of studies using testosterone Urinary androgen and glucocorticoid metabolite measurements seminiferous tubule to maintain a low level of spermatogenesis in the hypogonadotrophic (intratesticular) testosterone-depleted
The selected urinary steroids were measured by a method based on that of Bevan et al. (1986) , except for urinary testosterone and state. While there are some data suggesting an effect of epitestosterone which were measured according to the method of testosterone on adrenal androgens in women (Azziz et al., 1991; Cowan et al. (1991) . In brief, all urinary steroid conjugates were Polderman et al., 1995) , the effect of exogenous testosterone on hydrolysed using the enzyme extracted from Helix pomatia, which adrenal androgen secretion in men has not previously been has predominantly glucuronidase activity combined with selective extensively studied (Dehennin and Matsumoto, 1993) . We sulphatase activity. Following ether extraction, testosterone and epiteshave therefore investigated adrenal androgen secretion by our tosterone were converted to their bis-trimethylsilyl ether derivatives subjects before and during TE suppression of spermatogenesis.
for analysis by capillary column gas chromatography-mass spectrophotometry. Other steroids were converted to methyloxime-trimethylsilyl ether derivatives for analysis on a model 438 gas chromatograph
Materials and methods
(Packer-Becker BV, Delft, Netherlands) fitted with a 'Flexsil' 25 mϫ0.32 mm capillary column coated with OV-1 (Phase-Sep, QueenSubjects and design sferry, Clywd) and quantified by comparison with peak height of the Thirty-three healthy Caucasian men aged 21-41 years (mean 31 Ϯ 1 internal standards. Methoxime formation prior to trimethylsilyl ether SEM) were recruited into a clinical efficacy trial of hormonal male derivatization is important for the thermal stability of the pregnane contraception after screening medical examination and biochemical type structures, e.g. pregnanetriol, but is not necessary for the analysis and haematological analyses. This study was part of a World Health of androgens. Between-batch coefficients of variation for both methods Organization multicentre trial investigating the contraceptive efficacy were Ͻ10%. of testosterone-induced severe oligozoospermia. Further details concerning volunteer recruitment can be found in the World Health Statistical analysis Organization (1996) publication. All subjects produced two baseline Statistical analyses were performed by analysis of variance, with pretreatment semen samples with sperm concentrations of Ͼ20ϫ10 6 / P Ͻ 0.05 regarded as significant. Results are expressed as ml, and blood samples with concentrations of gonadotrophins and mean Ϯ SEM. testosterone within the reference range for adult males. Each subject received 200 mg testosterone oenanthate (TE, 'Testoviron'; Schering AG, Berlin, Germany) i.m. weekly, and were required to use this as Results their only method of contraception for one year once their sperm concentration had fallen to below 5ϫ10 6 /ml. at up to 40 weeks of continued TE administration.
Sperm concentration
All blood samples were taken between 9 a.m. and 12.30 a.m. The repeat samples were taken 7 days after the last TE injection, i.e. 159 Ϯ 24 to 685 Ϯ 142 nmol/24 h in the oligozoospermic group (both P Ͻ 0.001, Figure 1b) . Plasma concentrations of Plasma steroid assays androstenedione were increased from 6.8 Ϯ 0.5 to Plasma concentrations of testosterone, androstenedione and 17OH-9.3 Ϯ 0.5 nmol/l (P Ͻ 0.001) in the azoospermic group, and progesterone were measured by established in-house radioimmunofrom 6.9 Ϯ 0.5 to 8.5 Ϯ 0.7 nmol/l (P Ͻ 0.005) in the oligozooassays (Corker and Davidson, 1978; Wallace and Wood, 1984) , and spermic group (data not shown). There were no differences dehydroepiandrosterone sulphate (DHAS) by radioimmunoassay using between the azoospermic and oligozoospermic groups either a commercial kit (Diagnostic Products Corporation). Cross-reactivity at baseline or after 16 weeks TE treatment in either plasma or with testosterone was Ͻ0.5% in the androsterone assay and Ͻ1% in urinary testosterone. the 17OH-progesterone assay. Epitestosterone was known not to TE treatment greatly reduced urinary excretion of epitestoscross-react with testosterone or androstenedione. In all cases, intraand interassay coefficients of variation were Ͻ10%.
Plasma and urinary testicular androgens
terone in all subjects, from 212 Ϯ 36 to 18.3 Ϯ 2.1 nmol/24 h Values given are mean Ϯ SEM. *P Ͻ 0.01, **P Ͻ 0.005, ***P Ͻ 0.001 versus pretreatment.
(P Ͻ 0.001) in the azoospermic responders and from 175 Ϯ 31 10.4 Ϯ 1.1 to 9.3 Ϯ 0.8 µmol/l (P Ͻ 0.05) and 3.1 Ϯ 0.5 to to 16.1 Ϯ 2.1 nmol/24 h (P Ͻ 0.005) in the oligozoospermic 1.8 Ϯ 0.5 µmol/24 h (P Ͻ 0.001) respectively. The decrease responders (Figure 1c) . The mean urinary testosterone/epitestoin plasma DHAS was observed in the azoospermic group sterone ratio increased from 1.5 to 47.2 in the azoospermic (from 11.5 Ϯ 1.6 to 9.4 Ϯ 1.0 µmol/l, P Ͻ 0.02) but there responders (range of individual values during TE treatment was no change in the oligozoospermic group (9.1 Ϯ 1.3 to 4.4-183) and from 1.0 to 43.2 in the oligozoospermic respond-9.1 Ϯ 1.4 µmol/l) (Figure 2 ). Urinary excretion of DHA ers (range 4.9-76). There were no differences between the showed similar changes in the azoospermic group, falling azoospermic and oligozoospermic groups either at baseline or from 3.2 Ϯ 0.7 to 1.3 Ϯ 0.4 µmol/24 h (P Ͻ0.002), but was after 16 weeks TE treatment in these measures. unchanged in the oligozoospermic group (2.9 Ϯ 0.9 to Plasma concentrations of 17OH-progesterone were reduced 2.5 Ϯ 1.1 µmol/24 h) (Figure 2 ). There were, however, no in both groups: from 4.6 Ϯ 0.4 to 2.5 Ϯ 0.2 nmol/l in the significant differences in plasma DHAS or urinary DHA azoospermic group (P Ͻ 0.001), and from 5.4 Ϯ 0.3 to between the azoospermic and oligozoospermic groups either 2.4 Ϯ 0.2 nmol/l in the oligozoospermic group (P Ͻ 0.001) pretreatment or during TE treatment. after 16 weeks of TE treatment (Figure 1d ). Urinary pregnaneChanges in the excretion of the androgen metabolites 16-triol excretion was also significantly reduced in both groups hydroxydehydroepiandrosterone (16OH-DHA), 11β-hydroxyafter 16 weeks of TE treatment. In the azoospermic group, androsterone (11β-OHA) and 11β-hydroxyaetiocholanolone pregnanetriol excretion was reduced from 2.8 Ϯ 0.4 to (11β-OHE) are shown in Table I . The decrease in excretion of 1.8 Ϯ 0.3 µmol/24 h (P Ͻ 0.005), and in the oligozoospermic 11β-OHE in the azoospermic group was at the level of group from 3.0 Ϯ 0.4 to 1.6 Ϯ 0.4 µmol/24 h (P Ͻ 0.01) statistical significance (P ϭ 0.05). (Figure 1e ). There were no significant differences between the azoospermic and oligozoospermic groups either at baseline or Urinary adrenal glucocorticoid metabolites after 16 weeks TE treatment.
Values for the urinary excretion of the glucocorticosteroid Plasma and urinary adrenal androgens metabolites tetrahydrocortisol (THF), allo-tetrahydrocortisol (aTHF), and tetrahydrocorticosterone (THE), and α-and β-After 16 weeks of TE treatment, plasma concentrations of DHAS and urinary excretion of DHA were reduced from cortolone pretreatment and after 16 weeks TE treatment are in the plasma concentration of androstenedione after 16 weeks of TE treatment in both groups of men. This elevation in plasma androstenedione concentration probably reflects shown in Table I . There were no significant changes in any of increased peripheral back-conversion from testosterone these metabolites during TE treatment.
( Sansone-Bezzano et al., 1979; Toth and Faredin, 1985) . These changes predominantly reflect the exogenous testosterone Discussion administered consistent with the supraphysiological dose of testosterone used in the present prototype regime. These We have previously found no difference in the pharmacokinetics and pharmacodynamics of testosterone enanthate in findings also imply that maintenance of spermatogenesis in oligozoospermic responders is not the result of differences azoospermic compared to oligozoospermic responders during TE treatment, nor in the rate or degree of suppression of in concentrations of testosterone or androstenedione in the peripheral circulation. gonadotrophin secretion which fall to undetectable levels in all men (Anderson and Wu, 1996) . However, higher 5α-Epitestosterone is secreted by the testis (Dehennin, 1993), although there may also be a minor adrenocortical contribution reductase activity in the oligozoospermic compared to the azoospermic responders was found during TE treatment (And- (Wilson and Lipsett, 1966; Tamm et al., 1966) . After 16 weeks TE treatment, urinary epitestosterone excretion in both erson et al., 1996) . We therefore postulated that increased 5α-reductase activity during gonadotrophin suppression, serving azoospermic and oligozoospermic responders was reduced to Ͻ10% of baseline. Our results are consistent with those to preserve some androgenic stimulus to the seminiferous tubules in the oligozoospermic but not the azoospermic responobtained using short-duration urine collections (Dehennin and Matsumoto, 1993) and plasma levels (Handelsman et al., ders, may account for the maintenance of a low level of spermatogenesis. To further investigate this hypothesis, we 1996) and confirm that the testes are the major source of epitestosterone. Since epitestosterone is an indicator of Leydig have now explored whether there are differences in the extent of suppression of endogenous testicular or adrenal androgens, cell activity, the present results also suggest that endogenous testicular steroidogenesis has been drastically curtailed as a precursors for 5α-reductase, which could differentiate azoospermic and oligozoospermic response groups following TE result of luteinizing hormone inhibition by exogenous TE (Anderson and Wu, 1996; Handelsman et al., 1996) . This suppression.
Exogenous testosterone is able to maintain spermatogenesis is compatible with the 90% reduction in directly-measured intratesticular testosterone levels reported in normal men directly in some animal species (see review by Weinbauer and Nieschlag, 1990) . Plasma concentrations and urinary excretion treated with testosterone propionate (Morse et al., 1973) . The decrease in markers of other secreted testicular intermediate of testosterone were increased by exogenous TE treatment, steroidogenic products, 17OH-progesterone and its urinary groups. The implications of this finding require further investigation. metabolite pregnanetriol (Strott et al., 1969; Laatikainen et al., 1971; Hammond et al., 1977; Nankin et al., 1980 ) is a further sign of suppressed Leydig cell function. Thus, using
